Edition:
United States

SenesTech Inc (SNES.OQ)

SNES.OQ on NASDAQ Stock Exchange Capital Market

0.66USD
14 Dec 2017
Change (% chg)

-- (--)
Prev Close
$0.66
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
83,210
52-wk High
$10.44
52-wk Low
$0.62

Summary

Name Age Since Current Position

Loretta Mayer

67 2004 Chairman of the Board, Chief Executive Officer, Chief Scientific Officer

Cheryl Dyer

64 2004 President, Chief Research Officer, Director

Grover Wickersham

67 2015 Independent Vice Chairman of the Board

Thomas Chesterman

56 2015 Chief Financial Officer, Executive Vice President, Treasurer, Assistant Secretary

Andrew Altman

2017 Chief Operating Officer, Executive Vice President

Kim Wolin

61 2014 Executive Vice President - Operations, Secretary

Marc Dumont

73 2016 Independent Director

Matthew Szot

42 2015 Independent Director

Julia Williams

56 2011 Independent Director

Biographies

Name Description

Loretta Mayer

Ms. Loretta P. Mayer, Ph.D., is a Chairman of the Board, Chief Executive Officer, Chief Scientific Officer of the Company. She is one of our co-founders, and has served as our chair of the board since our inception in July 2004. Since June 2009, Dr. Mayer has served as our chief scientific officer. In December 2015, she assumed the title of chief executive officer, a position she previously held from June 2011 to January 2015. She is a co-inventor on the patent licensed from the University of Arizona that formed the basis for the launch of our research and development efforts and continues to contribute as co-inventor on additional patent improvements and new technology. Prior to her career in medicine and science, from 1978 to 1991 Dr. Mayer served as CEO of Binnacle Development, Inc., a California-based Real Estate Development company, where she established the first Senior Citizen Housing project in the city of San Diego, developed $45 million in product and managed an annual budget of $10 million. Dr. Mayer also served as Vice President of Soroptimist International of the Americas from 1990 to 1991, where she was responsible for NGO representation at United Nations and international board meetings, Cambridge, UK 1990 – 1991. She also served Soroptimist International of the Americas as a federation board member from 1988 to 1990 and as regional governor from 1984 to 1986. She earned a master’s degree in 1997 and a Ph.D. in 2000 in Biology from Northern Arizona University. Dr. Mayer earned a bachelors degree in Sociology from University of California, San Diego in 1971. She accepted a post-doctoral appointment with the College of Medicine at the University of Arizona in 2000.

Cheryl Dyer

Ms. Cheryl A. Dyer, Ph.D., is a President, Chief Research Officer, Director of the Company. She is one of our co-founders and has served as our president and a member of our board of directors since our inception in July 2004. She has served as our chief research officer since 2004, where she oversees all of our research activities for relevance to our business goals, adherence to scientific standards and assurance of regulatory, legal and contractual compliance. From June 1990 to September 2010, Dr. Dyer served as a NIH-funded Principal Investigator at The Scripps Research Institute, La Jolla, California and Northern Arizona University, Flagstaff, Arizona where she maintained an independently-funded research program and laboratory. She was the first Research Professor in the Department of Biology at Northern Arizona University in 1995 and the first Established Investigator for the American Heart Association in the State of Arizona. Dr. Dyer earned a Bachelor’s degree in Biology from the University of California at San Diego in 1974 and a Ph.D. in Physiology and Pharmacology in 1986 in the School of Medicine at University of California at San Diego. Dr. Dyer was appointed as an Adjunct Member of the Graduate Faculty at Texas A&M University in 2015.

Grover Wickersham

Mr. Grover T. Wickersham is a Independent Vice Chairman of the Board of the Company. He was elected to our board of directors and appointed as its Vice Chairman in December 2015. Mr. Wickersham is also Vice Chairman of the board of directors of S&W Seed Company, a NASDAQ-traded agricultural company, Chairman of the Board of Eastside Distilling, Inc., an OTCQB-traded producer and “micro” distiller of spirits, a director of Verseon Corporation, a London AIM-listed pharmaceutical development company, and Vice Chairman of Arbor Vita Corporation, a private company that has developed a test for cervical cancer. Mr. Wickersham has been a director and portfolio advisor of Glenbrook Capital Management, the general partner of a partnership that invests primarily in securities, from 1996 to present. From 1996 to 2016, Mr. Wickersham has served as the chairman of the board of trustees of Purisima Fund, a mutual fund advised by Fisher Investments of Woodside, California. Mr. Wickersham is admitted to practice by the California State Bar and has specialized in securities law. From 1976 to 1981, Mr. Wickersham served as a staff attorney, and then as a branch chief, of the U.S. Securities and Exchange Commission. He holds an A.B. from the Univ. of California at Berkeley, an M.B.A. from Harvard Business School and a J.D. from Univ. of California (Hastings).

Thomas Chesterman

Mr. Thomas C. Chesterman is a Chief Financial Officer, Executive Vice President, Treasurer, Assistant Secretary of the Company. He joined our company in September 2015, and has served as our chief financial officer and treasurer since November 2015. He has over 20 years of experience as the chief financial officer of a public company in the life science, tech and telecommunications industries. Most recently, he was the vice president and treasurer of General Communication Inc., a telecommunications company in Alaska, from 2013 to 2015. Previously, he was the chief financial officer of life science companies Bionovo Inc. from 2007 to 2012, Aradigm Corp. from 2002 to 2007 and Bio-Rad Laboratories, Inc. from 1996 to 2002. Mr. Chesterman is adept at a variety of capital market access techniques, and has significant experience in developing the operational and financial infrastructures in companies to help support successful and rapid growth. Mr. Chesterman earned a bachelor’s degree from Harvard University and an MBA from the University of California at Davis.

Andrew Altman

Mr. Andrew Altman has been appointed as Chief Operating Officer, Executive Vice President of the Company effective June 19, 2017(with an anticipated start date of June 19, 2017). Mr. Altman will also serve as an Executive Vice President of the Company. Prior to joining SenesTech, from 2012 to 2017, Mr. Altman was Vice President and General Manager at Idexx BioResearch, a provider of biological materials testing and laboratory animal diagnostic instruments and services, a division of Idexx Laboratories. From 2008 to 2012, he was Vice President of Thermo Fischer Scientific, where he oversaw manufacturing, marketing and research and development. From 2005 to 2008, he was co-founder and president of IT Imaging. Prior to IT Imaging, he held various sales manager roles with Varian, Inc. and Fision Instruments (formerly VG Instruments).

Kim Wolin

Ms. Kim Wolin is a Executive Vice President - Operations, Secretary of the Company. She joined our company as a marketing technologist in May 2013, and in May 2014 was appointed executive vice president of operations. From January 2009 to May 2013, she was a vice president, branch sales and service manager of Sunwest Bank, a community bank located in Flagstaff, Arizona. From November 1996 to December 2009, Ms. Wolin held the positions of assistant vice president, branch manager and Licensed Financial Advisor at Wells Fargo Bank. She has owned and operated Creative Net Solutions, a website design and hosting business, since 1994. From 1984 to 1992, Ms. Wolin owned and operated Kodas Produce Market, a health food and organic produce store in Oakland, CA. Ms. Wolin earned a bachelor’s degree in Psychology from the State University of New York/Buffalo in 1977.

Marc Dumont

Mr. Marc Dumont is a Independent Director of the Company. He was elected to our board of directors in January 2016. Mr. Dumont is chairman and chief executive officer of Chateau de Messey Wineries, Meursault, France, a position he has held since March 1995. Mr. Dumont served as the president of PSA International SA (a PSA Peugeot Citroen Group company) from January 1981 to March 1995. He is an international financial consultant and advisor for clients in Europe and Asia, as well as the United States. He has served as the chairman of Sanderling Ventures (a European affiliate of a U.S. venture capital firm) since 1996. In the past, Mr. Dumont has served as director of Finter Bank Zurich, Novalog/Winslow Corporation, NUKO Information Systems Inc. in San Jose, CA, and Banque Internationale in Luxembourg, all of which were public companies. Mr. Dumont holds a Degree in Electrical Engineering and Applied Economics from the University of Louvain, Belgium and an MBA from the University of Chicago.

Matthew Szot

Mr. Matthew K. Szot is a Independent Director of the Company. He was elected to our board of directors in December 2015 and appointed as the chairman of the audit committee of our board of directors in December 2015 and as the chairman of the compensation committee of our board of directors in July 2016. Since March 2010, he has served as the chief financial officer and treasurer of S&W Seed Company, a NASDAQ-listed agricultural seed company. From February 2007 until October 2011, Mr. Szot served as the chief financial officer for Cardiff Partners, LLC, a strategic consulting company that provided executive financial services to various publicly traded and privately held companies. From July 2011 until October 2011, Mr. Szot also served as the chief financial officer for CommerceTel Corporation N/K/A Mobivity Holdings Corp. From 2003 to December 2006, Mr. Szot served as chief financial officer and Secretary of Rip Curl, Inc., a market leader in wetsuit and action sports apparel products. From 1996 to 2003, Mr. Szot was a Certified Public Accountant with KPMG and served as an Audit Manager for various publicly traded companies. Mr. Szot has a Bachelor of Science degree in Agricultural Economics/Accountancy from the University of Illinois, Champaign-Urbana and is a Certified Public Accountant in the State of California.

Julia Williams

Dr. Julia Williams, M.D., is a Independent Director of the Company. She was elected to our board of directors in August 2011. She has been an emergency department physician since 1989. She has worked at Flagstaff Medical Center since 1999. Dr. Williams is the founder and President of Humanitarian Efforts Reaching Out, or HERO, a non-profit 501(c)(3) organization that provides humanitarian services including medical and dental care, alternative power sources, solar cookers, vitamins, eye glasses, nutritional support and animal care. HERO’s mission is to help build healthy sustainable communities in underdeveloped Nations around the world. Dr. Williams has received her Doctor of Medicine from the University of Maryland School of Medicine and her Bachelors of Science from the University of Maryland.

Basic Compensation

Name Fiscal Year Total

Loretta Mayer

2,613,660

Cheryl Dyer

2,584,150

Grover Wickersham

--

Thomas Chesterman

861,600

Andrew Altman

--

Kim Wolin

--

Marc Dumont

--

Matthew Szot

--

Julia Williams

--
As Of  30 Dec 2015